Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.
Cancer
; 116(17): 4114-21, 2010 Sep 01.
Article
in En
| MEDLINE
| ID: mdl-20564116
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glycoproteins
/
Biomarkers, Tumor
/
Carcinoma, Non-Small-Cell Lung
/
Lectins
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer
Year:
2010
Document type:
Article
Affiliation country:
Germany